Skip to main content

Table 2 Evaluation of protection induced by multicomponent vaccine after intranasal challenge with S. suis cps14 strain V3117/2

From: Immunogenicity and protective efficacy of a Streptococcus suis vaccine composed of six conserved immunogens

Immunization Morbidity Mortality Mean
Clinical score
(SD)
Clinical signs Max. body temperature (°C)
  CNSa Lameness No feed intake    < 40  ≥ 40 and ≤ 40.2  > 40.2
Placebo 4/8 2/8 7 (11.1) 0/8 2/8 2/8 4/8 0/8 4/8
Vaccine 5/8 3/8 11 (12.0) 1/8 3/8 3/8 3/8 1/8 4/8
  1. aSigns of central nervous system (CNS) dysfunction such as convulsions and opisthotonus.